Fellowship Established in Dr. Gary S. Hoffman’s Honor

The Vasculitis Foundation is pleased to announce the 2016 Gary S. Hoffman Vasculitis Foundation Fellowship in honor of Dr. Hoffman, who has had a profound influence on the lives of people with vasculitis and is recognized as a world leader in vasculitis clinical care and research.

Upon the announcement of his retirement from patient care in late 2014, the VF Board of Directors chose to recognize Dr. Hoffman by partnering with the Cleveland Clinic Center for Vasculitis Care and Research to fund a yearlong fellowship at the Center for Vasculitis Care and Research through the VF Fellowship Program.

l-r: Dr. Hiromichi Tamaki, Dr. Gary S. Hoffman, and Dr. Carol A. Langford

Joyce Kullman, executive director of the VF, and Dr. Carol Langford, director of the Center, announced the Hoffman fellowship in a special ceremony during the VF Patient and Family Vasculitis Conference in Cleveland, Ohio on April 28.

Dr. Langford introduced Dr. Hiromichi “Hiro” Tamaki as the Hoffman fellow. Dr. Tamaki graduated from the University of Tokyo and completed an Internal Medicine Residency at the University of Hawaii followed by a rheumatology fellowship at the Cleveland Clinic. He will begin the first year of the two-year vasculitis fellowship in July 2015.

Dr. Hoffman received his medical degree from the Medical College of Virginia and pursued advanced training in medicine and rheumatology at Dartmouth Medical School-Mary Hitchcock Clinic. Being first a clinician, then a researcher, patient experiences have steered his research in many unique directions, including calcium oxalate arthropathy in ESRD, inflammatory muscle disease, arachnoiditis and lupus.

Choosing Vasculitis

In 1987, Dr. Hoffman joined the Vasculitis and Related Diseases Section at the National Institutes of Health (NIH); run by Dr. Anthony S. Fauci, who with Dr. Shelly Wolf, discovered in 1973 that daily prednisone and cyclophosphamide induced remission in patients with Wegener’s, although the regimen was associated with very serious side effects.

Dr. Hoffman became head of the NIH Section in 1991 and since then has focused his career on vasculitis patient care and research. He recognized that although cyclophosphamide and prednisone helped patients with Wegener’s, it was critically important to develop other medications to help patients avoid permanent health complications from the two drugs. Dr. Hoffman worked tirelessly to not only find better treatment options but to improve the overall quality of life for patients with vasculitis. He has a distinct ability to sympathize and relate to the patient experience and his work is evidence of this.

In 1992, Dr. Hoffman joined the Cleveland Clinic as the Harold C. Schott Chair of the Department of Rheumatic and Immunologic Diseases. He is the founder of the Cleveland Clinic Center for Vasculitis Care and Research and is also the founder and past chairman of the International Network for the Study of the Systemic Vasculitides (INSSYS).

Dr. Hoffman led investigations of new therapies for vasculitis and coordinated the first international multi-center studies of diagnostic laboratory and imaging tools to assess vasculitis disease activity. These multi-center studies proved that research involving large cohorts of patients could be done successfully by collaborating with other vasculitis researchers around the world.

Dr. Hoffman is a longtime VF Medical Consultant and has helped guide the organization for almost 30 years. He served on the VF Board of Directors from 2010-2013 and was instrumental in helping expand the VF Research Program to support fellowships.

Jason Wadler, president of the VF Board said, “We are extremely grateful for Dr. Hoffman’s leadership, dedication and support of the Vasculitis Foundation. On behalf of the VF board, staff and our entire vasculitis community, we thank Dr. Hoffman for his kindness, generosity, compassion and above all else, the tremendous care he has shown all of us.”

Support the Fellowship
You may help us honor Dr. Hoffman by making a contribution to the Vasculitis Foundation Gary S. Hoffman Fellowship here.  We will notify Dr. Hoffman of your generous donation and your tribute to his legacy.

In honor of Dr. Hoffman, we have created a video featuring many of Dr. Hoffman’s colleagues and patients discussing the impact of his work in the field of vasculitis. Click here to watch the video.

Fave_Icon_16x16

Vasculitis Foundation

The Vasculitis Foundation is the international organization for patients with vasculitis, their families, friends and the health care professionals who care for them.


Introducing our 2017-2018 VCRC-VF Fellow

Kaitlin Quinn, MD, is the recipient of the 2017 VCRC-VF Fellowship.  She received her medical degree from New York Medical College in Valhalla, New York.   She completed her Internal Medicine more »

FDA Approves Genentech’s Actemra® for Giant Cell Arteritis

Genentech, a member of the Roche Group, announced today (May 22, 2017) that the U.S. Food and Drug Administration (FDA) has approved Actemra® (tocilizumab) subcutaneous injection for the treatment of more »

Brandon Hudgins to Receive NORD Rare Impact Award at May 18th Ceremony

On  Thursday, May 18,  Brandon Hudgins will be accepting the NORD 2017 Rare Impact Award.   The VF  nominated Brandon, a record-breaking, elite runner, for his work raising awareness about more »


Vasculitis Update 2017 CME Course: Chicago, June 24

The Vasculitis Foundation is pleased to present the 2017 Vasculitis Update CME Course for health care professionals in partnership with Northwestern Division of Rheumatology on Saturday, June 24, 2017 from 7:45 more »

Main Line Health Medical Professional Wins National Award for Early Diagnosis of Rare Disease

The Vasculitis Foundation (VF) announces the winner of its 2017 Recognizing Excellence in Diagnostics (RED) Award.  The V-RED Award is presented annually to a medical professional who made a quick diagnosis of more »